期刊
JOURNAL OF CELLULAR PHYSIOLOGY
卷 233, 期 8, 页码 5523-5529出版社
WILEY
DOI: 10.1002/jcp.26348
关键词
central nervous system; multiple sclerosis; myelination; pericytes
资金
- National Cancer Institute [1R01CA179072-01A1]
- American Cancer Society [124443-MRSG-13121]
- Serrapilheira Institute [G-1708-15285]
- Pro-reitoria de Pesquisa/Universidade Federal de Minas Gerais (PRPq/UFMG) [Edital 05/2016]
- FAPEMIG [Rede Mineira de Engenharia de Tecidos e Terapia Celular, REMETTEC] [RED-00570-16]
- FAPEMIG [Rede De Pesquisa Em Doencas Infecciosas Humanas E Animais Do Estado De Minas Gerais] [RED-00313-16]
- National Institute of Health [1R01CA179072-01A1]
- American Cancer Society Mentored Research Scholar [124443-MRSG-13-121-01-CDD]
Multiple sclerosis is a highly prevalent chronic demyelinating disease of the central nervous system. Remyelination is the major therapeutic goal for this disorder. The lack of detailed knowledge about the cellular and molecular mechanisms involved in myelination restricts the design of effective treatments. A recent study by using [De La Fuente et al. (2017) Cell Reports, 20(8): 1755-1764] by using state-of-the-art techniques, including pericyte-deficient mice in combination with induced demyelination, reveal that pericytes participate in central nervous system regeneration. Strikingly, pericytes presence is essential for oligodendrocyte progenitors differentiation and myelin formation during remyelination in the brain. The emerging knowledge from this research will be important for the treatment of multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据